Evaluation of Executive Functions in Children With Cochleovestibular Deficit

Hearing Loss Clinical Trial

— Vestibulex  

Official title:

Evaluation of Executive Functions in Children With Cochleovestibular Deficit

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05665907
• Other study ID #: APHP220224
• Secondary ID: IDRCB: 2022-A001
• Status: Not yet recruiting
• Start date: January 1, 2023
• Est. completion date: January 1, 2024

Study information

• Verified date: November 2022
• Source: Assistance Publique - Hôpitaux de Paris
• Contact: Audrey MAUDOUX, MD
• Phone: +331 40 03 24 49
• Email: audrey.maudoux[@]aphp.fr
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Vestibular system activity supports many functions ranging from gaze stabilization and postural control to high-level cortical functions involving spatial cognition, body perception, verticality perception, orientation, navigation, and spatial memory. Few studies have assessed the impact of a vestibular deficit on executive functions taking into account the simultaneous existence of sensorineural deafness in a child population. The BRIEF questionnaire (Behavioral Rating Inventory of Executive Function) allows a parental assessment of executive functions and is validated from the age of 5. Children were recruited from a pediatric population followed in the Ear Nose and Throat (ENT) department for audio-vestibular assessment and BRIEF questionnaire was completed by the accompanying parent.

Description:

Vestibular system activity supports many functions ranging from gaze stabilization and postural control to high-level cortical functions involving spatial cognition, body perception, verticality perception, orientation, navigation, and spatial memory. Few studies have assessed the impact of a vestibular deficit on executive functions taking into account the simultaneous existence of sensorineural deafness in a child population. The BRIEF questionnaire (Behavioral Rating Inventory of Executive Function) allows a parental assessment of executive functions and is validated from the age of 5. Children were recruited from a pediatric population followed in the Ear Nose and Throat (ENT) department for audio-vestibular assessment and BRIEF questionnaire was completed by the accompanying parent.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: January 1, 2024
• Est. primary completion date: January 1, 2024
• Gender: All
• Age group: 5 Years to 18 Years

Eligibility

Inclusion Criteria:

• Patient aged = 5 years < 18 years with vestibulopathy confirmed during an ENT consultation
• Affiliated to the social security system
• Holders of parental authority and Patients informed and not opposed to participating in the research
• Mastery of the French language by patients and their parents

Exclusion Criteria:

• Refusal to participate
• Existence of another neurodevelopmental pathology or specific cognitive disorder

Related Conditions & MeSH terms

• Cognitive Function
• Executive Function
• Hearing Loss

Intervention

Other:
• Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)
Questionnaire BRIEF (Behavioral Rating Inventory of Executive Function)

Locations

Country	Name	City	State
France	Robert Debre Hospital	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Global scores on the BRIEF (Behavioral Rating Inventory of Executive Function) questionnaire	Comparison of global scores obtained in children with vestibular dysfunction, with hearing loss or normal inner ear function	1 year